BEGIN:VCALENDAR
PRODID:-//Synedi//Hearing Calendar//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:336785@synedi.ai
DTSTAMP:20260708T001119Z
DTSTART;TZID=America/New_York:20250403T101500
DTEND;TZID=America/New_York:20250403T121500
SUMMARY:Business meeting to consider S.527\, to require the Federal Trade C
 ommission to study the role of intermediaries in the pharmaceutical supply
  chain and provide Congress with appropriate policy recommendations\, S.10
 40\, to amend the Federal Trade Commission Act to prohibit product hopping
 \, S.1041\, to amend title 35\, United States Code\, to address the infrin
 gement of patents that claim biological products\, S.1097\, to amend title
  35\, United States Code\, to establish an interagency task force between 
 the United States Patent and Trademark Office and the Food and Drug Admini
 stration for purposes of sharing information and providing technical assis
 tance with respect to patents\, S.1095\, to enable the Federal Trade Commi
 ssion to deter filing of sham citizen petitions to cover an attempt to int
 erfere with approval of a competing generic drug or biosimilar\, to foster
  competition\, and facilitate the efficient review of petitions filed in g
 ood faith to raise legitimate public health concerns\, and S.1096\, to pro
 hibit brand name drug companies from compensating generic drug companies t
 o delay the entry of a generic drug into the market\, and to prohibit biol
 ogical product manufacturers from compensating biosimilar and interchangea
 ble companies to delay the entry of biosimilar biological products and int
 erchangeable biological products\, and the nomination of Patrick David Dav
 is\, of Maryland\, to be an Assistant Attorney General\, Department of Jus
 tice.
LOCATION:Hart 216
DESCRIPTION:Judiciary Committee\nStatus: Scheduled\nhttps://synedi.ai/heari
 ng/s527-require-federal-trade-commission-study-role-intermediaries-2025
URL:https://synedi.ai/hearing/s527-require-federal-trade-commission-study-r
 ole-intermediaries-2025
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR